APO Research

APO RESEARCH · REPORT

Exoskeleton Enhancement Device

Selected research

Industry Growth & Trends

Global Exoskeleton Enhancement Device Industry Growth and Trends Forecast to 2032

Market perspective

The global Exoskeleton Enhancement Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Exoskeleton Enhancement Device include Parker Hannifin, US Bionics, ReWalk Robotics, Panasonic, Myomo, LockHeed Martin, Interactive Motion Technologies, Hocoma and Ekso Bionics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Exoskeleton Enhancement Device market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Exoskeleton Enhancement Device market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Exoskeleton Enhancement Device market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Exoskeleton Enhancement Device.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Exoskeleton Enhancement Device market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Exoskeleton Enhancement Device Market by Company

Parker Hannifin

US Bionics

ReWalk Robotics

Panasonic

Myomo

LockHeed Martin

Interactive Motion Technologies

Hocoma

Ekso Bionics

Cyberdyne

B-TEMIA Inc.

Alter G

Exoskeleton Enhancement Device Segment by Type

Lower

Upper

Full Body

Exoskeleton Enhancement Device Segment by Application

Healthcare

Defense

Others

Exoskeleton Enhancement Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exoskeleton Enhancement Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exoskeleton Enhancement Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exoskeleton Enhancement Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Exoskeleton Enhancement Device manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Exoskeleton Enhancement Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Lower Table 2. Major Company of Upper Table 3. Major Company of Full Body Table 4. Global Exoskeleton Enhancement Device Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 6. Global Exoskeleton Enhancement Device Sales Market Share in Volume by Type (2021-2026) Table 7. Global Exoskeleton Enhancement Device Sales by Type (2021-2026) & (US$ Million) Table 8. Global Exoskeleton Enhancement Device Sales Market Share in Value by Type (2021-2026) Table 9. Global Exoskeleton Enhancement Device Price by Type (2021-2026) & (K US$/Unit) Table 10. Global Exoskeleton Enhancement Device Sales by Type (2027-2032) & (Units) Table 11. Global Exoskeleton Enhancement Device Sales Market Share in Volume by Type (2027-2032) Table 12. Global Exoskeleton Enhancement Device Sales by Type (2027-2032) & (US$ Million) Table 13. Global Exoskeleton Enhancement Device Sales Market Share in Value by Type (2027-2032) Table 14. Global Exoskeleton Enhancement Device Price by Type (2027-2032) & (K US$/Unit) Table 15. North America Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 16. North America Exoskeleton Enhancement Device Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 18. Europe Exoskeleton Enhancement Device Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 20. Asia-Pacific Exoskeleton Enhancement Device Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 22. Latin America Exoskeleton Enhancement Device Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 24. Middle East and Africa Exoskeleton Enhancement Device Sales by Type (2021-2026) & (US$ Million) Table 25. Exoskeleton Enhancement Device Industry Trends Table 26. Exoskeleton Enhancement Device Industry Drivers Table 27. Exoskeleton Enhancement Device Industry Opportunities and Challenges Table 28. Exoskeleton Enhancement Device Industry Restraints Table 29. Global Exoskeleton Enhancement Device Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Exoskeleton Enhancement Device Revenue Market Share by Company (2021-2026) Table 31. Global Exoskeleton Enhancement Device Sales by Company (2021-2026) & (Units) Table 32. Global Exoskeleton Enhancement Device Sales Share by Company (2021-2026) Table 33. Global Exoskeleton Enhancement Device Market Price by Company (2021-2026) & (K US$/Unit) Table 34. Global Exoskeleton Enhancement Device Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Exoskeleton Enhancement Device Major Company Production Sites and Headquarters Table 36. Global Exoskeleton Enhancement Device Company, Product Type & Application Table 37. Global Exoskeleton Enhancement Device Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Exoskeleton Enhancement Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Exoskeleton Enhancement Device Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Exoskeleton Enhancement Device Sales by Region (2021-2026) & (Units) Table 42. Global Exoskeleton Enhancement Device Sales Market Share in Volume by Region (2021-2026) Table 43. Global Exoskeleton Enhancement Device Sales by Region (2021-2026) & (US$ Million) Table 44. Global Exoskeleton Enhancement Device Sales Market Share in Value by Region (2021-2026) Table 45. Global Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 46. Global Exoskeleton Enhancement Device Sales by Region (2027-2032) & (Units) Table 47. Global Exoskeleton Enhancement Device Sales Market Share in Volume by Region (2027-2032) Table 48. Global Exoskeleton Enhancement Device Sales by Region (2027-2032) & (US$ Million) Table 49. Global Exoskeleton Enhancement Device Sales Market Share in Value by Region (2027-2032) Table 50. Global Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2027-2032) Table 51. Global Exoskeleton Enhancement Device Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 53. Global Exoskeleton Enhancement Device Sales Market Share in Volume by Application (2021-2026) Table 54. Global Exoskeleton Enhancement Device Sales by Application (2021-2026) & (US$ Million) Table 55. Global Exoskeleton Enhancement Device Sales Market Share in Value by Application (2021-2026) Table 56. Global Exoskeleton Enhancement Device Price by Application (2021-2026) & (K US$/Unit) Table 57. Global Exoskeleton Enhancement Device Sales by Application (2027-2032) & (Units) Table 58. Global Exoskeleton Enhancement Device Sales Market Share in Volume by Application (2027-2032) Table 59. Global Exoskeleton Enhancement Device Sales by Application (2027-2032) & (US$ Million) Table 60. Global Exoskeleton Enhancement Device Sales Market Share in Value by Application (2027-2032) Table 61. Global Exoskeleton Enhancement Device Price by Application (2027-2032) & (K US$/Unit) Table 62. North America Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 63. North America Exoskeleton Enhancement Device Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 65. Europe Exoskeleton Enhancement Device Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 67. Asia-Pacific Exoskeleton Enhancement Device Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 69. Latin America Exoskeleton Enhancement Device Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 71. Middle East and Africa Exoskeleton Enhancement Device Sales by Application (2021-2026) & (US$ Million) Table 72. Parker Hannifin Company Information Table 73. Parker Hannifin Business Overview Table 74. Parker Hannifin Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 75. Parker Hannifin Exoskeleton Enhancement Device Product Portfolio Table 76. Parker Hannifin Recent Development Table 77. US Bionics Company Information Table 78. US Bionics Business Overview Table 79. US Bionics Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 80. US Bionics Exoskeleton Enhancement Device Product Portfolio Table 81. US Bionics Recent Development Table 82. ReWalk Robotics Company Information Table 83. ReWalk Robotics Business Overview Table 84. ReWalk Robotics Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 85. ReWalk Robotics Exoskeleton Enhancement Device Product Portfolio Table 86. ReWalk Robotics Recent Development Table 87. Panasonic Company Information Table 88. Panasonic Business Overview Table 89. Panasonic Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 90. Panasonic Exoskeleton Enhancement Device Product Portfolio Table 91. Panasonic Recent Development Table 92. Myomo Company Information Table 93. Myomo Business Overview Table 94. Myomo Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 95. Myomo Exoskeleton Enhancement Device Product Portfolio Table 96. Myomo Recent Development Table 97. LockHeed Martin Company Information Table 98. LockHeed Martin Business Overview Table 99. LockHeed Martin Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 100. LockHeed Martin Exoskeleton Enhancement Device Product Portfolio Table 101. LockHeed Martin Recent Development Table 102. Interactive Motion Technologies Company Information Table 103. Interactive Motion Technologies Business Overview Table 104. Interactive Motion Technologies Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 105. Interactive Motion Technologies Exoskeleton Enhancement Device Product Portfolio Table 106. Interactive Motion Technologies Recent Development Table 107. Hocoma Company Information Table 108. Hocoma Business Overview Table 109. Hocoma Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 110. Hocoma Exoskeleton Enhancement Device Product Portfolio Table 111. Hocoma Recent Development Table 112. Ekso Bionics Company Information Table 113. Ekso Bionics Business Overview Table 114. Ekso Bionics Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 115. Ekso Bionics Exoskeleton Enhancement Device Product Portfolio Table 116. Ekso Bionics Recent Development Table 117. Cyberdyne Company Information Table 118. Cyberdyne Business Overview Table 119. Cyberdyne Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 120. Cyberdyne Exoskeleton Enhancement Device Product Portfolio Table 121. Cyberdyne Recent Development Table 122. B-TEMIA Inc. Company Information Table 123. B-TEMIA Inc. Business Overview Table 124. B-TEMIA Inc. Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 125. B-TEMIA Inc. Exoskeleton Enhancement Device Product Portfolio Table 126. B-TEMIA Inc. Recent Development Table 127. Alter G Company Information Table 128. Alter G Business Overview Table 129. Alter G Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 130. Alter G Exoskeleton Enhancement Device Product Portfolio Table 131. Alter G Recent Development Table 132. North America Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 133. North America Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 134. North America Exoskeleton Enhancement Device Sales Market Share by Country (2021-2026) Table 135. North America Exoskeleton Enhancement Device Sales Forecast by Country (2027-2032) & (Units) Table 136. North America Exoskeleton Enhancement Device Sales Market Share Forecast by Country (2027-2032) Table 137. North America Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America Exoskeleton Enhancement Device Market Size by Country (2021-2026) & (US$ Million) Table 139. North America Exoskeleton Enhancement Device Market Share by Country (2021-2026) Table 140. North America Exoskeleton Enhancement Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America Exoskeleton Enhancement Device Market Share Forecast by Country (2027-2032) Table 142. Europe Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 143. Europe Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 144. Europe Exoskeleton Enhancement Device Sales Market Share by Country (2021-2026) Table 145. Europe Exoskeleton Enhancement Device Sales Forecast by Country (2027-2032) & (Units) Table 146. Europe Exoskeleton Enhancement Device Sales Market Share Forecast by Country (2027-2032) Table 147. Europe Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe Exoskeleton Enhancement Device Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe Exoskeleton Enhancement Device Market Share by Country (2021-2026) Table 150. Europe Exoskeleton Enhancement Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe Exoskeleton Enhancement Device Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 154. Asia-Pacific Exoskeleton Enhancement Device Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific Exoskeleton Enhancement Device Sales Forecast by Country (2027-2032) & (Units) Table 156. Asia-Pacific Exoskeleton Enhancement Device Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Exoskeleton Enhancement Device Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific Exoskeleton Enhancement Device Market Share by Country (2021-2026) Table 160. Asia-Pacific Exoskeleton Enhancement Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific Exoskeleton Enhancement Device Market Share Forecast by Country (2027-2032) Table 162. Latin America Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 163. Latin America Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 164. Latin America Exoskeleton Enhancement Device Sales Market Share by Country (2021-2026) Table 165. Latin America Exoskeleton Enhancement Device Sales Forecast by Country (2027-2032) & (Units) Table 166. Latin America Exoskeleton Enhancement Device Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America Exoskeleton Enhancement Device Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America Exoskeleton Enhancement Device Market Share by Country (2021-2026) Table 170. Latin America Exoskeleton Enhancement Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America Exoskeleton Enhancement Device Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 174. Middle East and Africa Exoskeleton Enhancement Device Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa Exoskeleton Enhancement Device Sales Forecast by Country (2027-2032) & (Units) Table 176. Middle East and Africa Exoskeleton Enhancement Device Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Exoskeleton Enhancement Device Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa Exoskeleton Enhancement Device Market Share by Country (2021-2026) Table 180. Middle East and Africa Exoskeleton Enhancement Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa Exoskeleton Enhancement Device Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Exoskeleton Enhancement Device Distributors List Table 185. Exoskeleton Enhancement Device Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Exoskeleton Enhancement Device Image Figure 2. Global Exoskeleton Enhancement Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Exoskeleton Enhancement Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Exoskeleton Enhancement Device Sales (2021-2032) & (Units) Figure 5. Lower Image Figure 6. Global Lower Sales YoY Growth (2021-2032) & (Units) Figure 7. Upper Image Figure 8. Global Upper Sales YoY Growth (2021-2032) & (Units) Figure 9. Full Body Image Figure 10. Global Full Body Sales YoY Growth (2021-2032) & (Units) Figure 11. Global Exoskeleton Enhancement Device Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Exoskeleton Enhancement Device Market Share by Type 2025 VS 2032 Figure 13. North America Exoskeleton Enhancement Device Sales Market Share in Volume by Type in 2025 Figure 14. North America Exoskeleton Enhancement Device Sales Market Share in Value by Type in 2025 Figure 15. Europe Exoskeleton Enhancement Device Sales Market Share in Volume by Type in 2025 Figure 16. Europe Exoskeleton Enhancement Device Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Exoskeleton Enhancement Device Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Exoskeleton Enhancement Device Sales Market Share in Value by Type in 2025 Figure 19. Latin America Exoskeleton Enhancement Device Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Exoskeleton Enhancement Device Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Exoskeleton Enhancement Device Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Exoskeleton Enhancement Device Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Exoskeleton Enhancement Device Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Healthcare Image Figure 26. Global Healthcare Sales YoY Growth (2021-2032) & (Units) Figure 27. Defense Image Figure 28. Global Defense Sales YoY Growth (2021-2032) & (Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 31. Global Exoskeleton Enhancement Device Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Exoskeleton Enhancement Device Market Share by Application 2025 VS 2032 Figure 33. North America Exoskeleton Enhancement Device Sales Market Share in Volume by Application in 2025 Figure 34. North America Exoskeleton Enhancement Device Sales Market Share in Value by Application in 2025 Figure 35. Europe Exoskeleton Enhancement Device Sales Market Share in Volume by Application in 2025 Figure 36. Europe Exoskeleton Enhancement Device Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Exoskeleton Enhancement Device Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Exoskeleton Enhancement Device Sales Market Share in Value by Application in 2025 Figure 39. Latin America Exoskeleton Enhancement Device Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Exoskeleton Enhancement Device Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Exoskeleton Enhancement Device Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Exoskeleton Enhancement Device Sales Market Share in Value by Application in 2025 Figure 43. North America Exoskeleton Enhancement Device Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 44. North America Exoskeleton Enhancement Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Exoskeleton Enhancement Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Exoskeleton Enhancement Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Exoskeleton Enhancement Device Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 48. Europe Exoskeleton Enhancement Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Exoskeleton Enhancement Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Exoskeleton Enhancement Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Exoskeleton Enhancement Device Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 52. Asia-Pacific Exoskeleton Enhancement Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Exoskeleton Enhancement Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Exoskeleton Enhancement Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Exoskeleton Enhancement Device Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 56. Latin America Exoskeleton Enhancement Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Exoskeleton Enhancement Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Exoskeleton Enhancement Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Exoskeleton Enhancement Device Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 60. Middle East and Africa Exoskeleton Enhancement Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Exoskeleton Enhancement Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Exoskeleton Enhancement Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Exoskeleton Enhancement Device Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Exoskeleton Enhancement Device Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Lower
  • Upper
  • Full Body
Applications
  • Healthcare
  • Defense
  • Others
Companies covered
  • Parker Hannifin
  • US Bionics
  • ReWalk Robotics
  • Panasonic
  • Myomo
  • LockHeed Martin
  • Interactive Motion Technologies
  • Hocoma
  • Ekso Bionics
  • Cyberdyne
  • B-TEMIA Inc.
  • Alter G

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Exoskeleton Enhancement Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Exoskeleton Enhancement Device Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Exoskeleton Enhancement Device Market by Type
  6. 1.3.1 Lower
  7. 1.3.2 Upper
  8. 1.3.3 Full Body
  9. 1.4 Global Exoskeleton Enhancement Device Market Size by Type
  10. 1.4.1 Global Exoskeleton Enhancement Device Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Exoskeleton Enhancement Device Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Exoskeleton Enhancement Device Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Exoskeleton Enhancement Device Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Exoskeleton Enhancement Device Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Exoskeleton Enhancement Device Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Exoskeleton Enhancement Device Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Exoskeleton Enhancement Device Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Exoskeleton Enhancement Device Industry Trends
  2. 2.2 Exoskeleton Enhancement Device Industry Drivers
  3. 2.3 Exoskeleton Enhancement Device Industry Opportunities and Challenges
  4. 2.4 Exoskeleton Enhancement Device Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Exoskeleton Enhancement Device Revenue (2021-2026)
  2. 3.2 Global Top Players by Exoskeleton Enhancement Device Sales (2021-2026)
  3. 3.3 Global Top Players by Exoskeleton Enhancement Device Price (2021-2026)
  4. 3.4 Global Exoskeleton Enhancement Device Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Exoskeleton Enhancement Device Major Company Production Sites & Headquarters
  6. 3.6 Global Exoskeleton Enhancement Device Company, Product Type & Application
  7. 3.7 Global Exoskeleton Enhancement Device Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Exoskeleton Enhancement Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Exoskeleton Enhancement Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Exoskeleton Enhancement Device Tier 1, Tier 2, and Tier 3
4 Exoskeleton Enhancement Device Regional Status and Outlook
  1. 4.1 Global Exoskeleton Enhancement Device Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Exoskeleton Enhancement Device Historic Market Size by Region
  3. 4.2.1 Global Exoskeleton Enhancement Device Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Exoskeleton Enhancement Device Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Exoskeleton Enhancement Device Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Exoskeleton Enhancement Device Forecasted Market Size by Region
  7. 4.3.1 Global Exoskeleton Enhancement Device Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Exoskeleton Enhancement Device Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Exoskeleton Enhancement Device Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Exoskeleton Enhancement Device by Application
  1. 5.1 Exoskeleton Enhancement Device Market by Application
  2. 5.1.1 Healthcare
  3. 5.1.2 Defense
  4. 5.1.3 Others
  5. 5.2 Global Exoskeleton Enhancement Device Market Size by Application
  6. 5.2.1 Global Exoskeleton Enhancement Device Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Exoskeleton Enhancement Device Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Exoskeleton Enhancement Device Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Exoskeleton Enhancement Device Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Exoskeleton Enhancement Device Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Exoskeleton Enhancement Device Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Exoskeleton Enhancement Device Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Exoskeleton Enhancement Device Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Parker Hannifin
  2. 6.1.1 Parker Hannifin Company Information
  3. 6.1.2 Parker Hannifin Business Overview
  4. 6.1.3 Parker Hannifin Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Parker Hannifin Exoskeleton Enhancement Device Product Portfolio
  6. 6.1.5 Parker Hannifin Recent Developments
  7. 6.2 US Bionics
  8. 6.2.1 US Bionics Company Information
  9. 6.2.2 US Bionics Business Overview
  10. 6.2.3 US Bionics Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 US Bionics Exoskeleton Enhancement Device Product Portfolio
  12. 6.2.5 US Bionics Recent Developments
  13. 6.3 ReWalk Robotics
  14. 6.3.1 ReWalk Robotics Company Information
  15. 6.3.2 ReWalk Robotics Business Overview
  16. 6.3.3 ReWalk Robotics Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 ReWalk Robotics Exoskeleton Enhancement Device Product Portfolio
  18. 6.3.5 ReWalk Robotics Recent Developments
  19. 6.4 Panasonic
  20. 6.4.1 Panasonic Company Information
  21. 6.4.2 Panasonic Business Overview
  22. 6.4.3 Panasonic Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Panasonic Exoskeleton Enhancement Device Product Portfolio
  24. 6.4.5 Panasonic Recent Developments
  25. 6.5 Myomo
  26. 6.5.1 Myomo Company Information
  27. 6.5.2 Myomo Business Overview
  28. 6.5.3 Myomo Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Myomo Exoskeleton Enhancement Device Product Portfolio
  30. 6.5.5 Myomo Recent Developments
  31. 6.6 LockHeed Martin
  32. 6.6.1 LockHeed Martin Company Information
  33. 6.6.2 LockHeed Martin Business Overview
  34. 6.6.3 LockHeed Martin Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 LockHeed Martin Exoskeleton Enhancement Device Product Portfolio
  36. 6.6.5 LockHeed Martin Recent Developments
  37. 6.7 Interactive Motion Technologies
  38. 6.7.1 Interactive Motion Technologies Company Information
  39. 6.7.2 Interactive Motion Technologies Business Overview
  40. 6.7.3 Interactive Motion Technologies Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Interactive Motion Technologies Exoskeleton Enhancement Device Product Portfolio
  42. 6.7.5 Interactive Motion Technologies Recent Developments
  43. 6.8 Hocoma
  44. 6.8.1 Hocoma Company Information
  45. 6.8.2 Hocoma Business Overview
  46. 6.8.3 Hocoma Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hocoma Exoskeleton Enhancement Device Product Portfolio
  48. 6.8.5 Hocoma Recent Developments
  49. 6.9 Ekso Bionics
  50. 6.9.1 Ekso Bionics Company Information
  51. 6.9.2 Ekso Bionics Business Overview
  52. 6.9.3 Ekso Bionics Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Ekso Bionics Exoskeleton Enhancement Device Product Portfolio
  54. 6.9.5 Ekso Bionics Recent Developments
  55. 6.10 Cyberdyne
  56. 6.10.1 Cyberdyne Company Information
  57. 6.10.2 Cyberdyne Business Overview
  58. 6.10.3 Cyberdyne Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Cyberdyne Exoskeleton Enhancement Device Product Portfolio
  60. 6.10.5 Cyberdyne Recent Developments
  61. 6.11 B-TEMIA Inc.
  62. 6.11.1 B-TEMIA Inc. Company Information
  63. 6.11.2 B-TEMIA Inc. Business Overview
  64. 6.11.3 B-TEMIA Inc. Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 B-TEMIA Inc. Exoskeleton Enhancement Device Product Portfolio
  66. 6.11.5 B-TEMIA Inc. Recent Developments
  67. 6.12 Alter G
  68. 6.12.1 Alter G Company Information
  69. 6.12.2 Alter G Business Overview
  70. 6.12.3 Alter G Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Alter G Exoskeleton Enhancement Device Product Portfolio
  72. 6.12.5 Alter G Recent Developments
7 North America by Country
  1. 7.1 North America Exoskeleton Enhancement Device Sales by Country
  2. 7.1.1 North America Exoskeleton Enhancement Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Exoskeleton Enhancement Device Sales by Country (2021-2026)
  4. 7.1.3 North America Exoskeleton Enhancement Device Sales Forecast by Country (2027-2032)
  5. 7.2 North America Exoskeleton Enhancement Device Market Size by Country
  6. 7.2.1 North America Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Exoskeleton Enhancement Device Market Size by Country (2021-2026)
  8. 7.2.3 North America Exoskeleton Enhancement Device Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Exoskeleton Enhancement Device Sales by Country
  2. 8.1.1 Europe Exoskeleton Enhancement Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Exoskeleton Enhancement Device Sales by Country (2021-2026)
  4. 8.1.3 Europe Exoskeleton Enhancement Device Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Exoskeleton Enhancement Device Market Size by Country
  6. 8.2.1 Europe Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Exoskeleton Enhancement Device Market Size by Country (2021-2026)
  8. 8.2.3 Europe Exoskeleton Enhancement Device Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Exoskeleton Enhancement Device Sales by Country
  2. 9.1.1 Asia-Pacific Exoskeleton Enhancement Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Exoskeleton Enhancement Device Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Exoskeleton Enhancement Device Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Exoskeleton Enhancement Device Market Size by Country
  6. 9.2.1 Asia-Pacific Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Exoskeleton Enhancement Device Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Exoskeleton Enhancement Device Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Exoskeleton Enhancement Device Sales by Country
  2. 10.1.1 South America Exoskeleton Enhancement Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Exoskeleton Enhancement Device Sales by Country (2021-2026)
  4. 10.1.3 South America Exoskeleton Enhancement Device Sales Forecast by Country (2027-2032)
  5. 10.2 South America Exoskeleton Enhancement Device Market Size by Country
  6. 10.2.1 South America Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Exoskeleton Enhancement Device Market Size by Country (2021-2026)
  8. 10.2.3 South America Exoskeleton Enhancement Device Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Exoskeleton Enhancement Device Sales by Country
  2. 11.1.1 Middle East and Africa Exoskeleton Enhancement Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Exoskeleton Enhancement Device Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Exoskeleton Enhancement Device Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Exoskeleton Enhancement Device Market Size by Country
  6. 11.2.1 Middle East and Africa Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Exoskeleton Enhancement Device Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Exoskeleton Enhancement Device Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Exoskeleton Enhancement Device Value Chain Analysis
  2. 12.1.1 Exoskeleton Enhancement Device Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Exoskeleton Enhancement Device Production Mode & Process
  7. 12.2 Exoskeleton Enhancement Device Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Exoskeleton Enhancement Device Distributors
  10. 12.2.3 Exoskeleton Enhancement Device Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research